A detailed history of Fulcrum Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fulcrum Capital LLC holds 1,275 shares of BDX stock, worth $291,324. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,275
Previous 1,275 -0.0%
Holding current value
$291,324
Previous $297,000 3.37%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$233.45 - $247.73 $64,198 - $68,125
275 Added 27.5%
1,275 $315,000
Q4 2023

Jan 10, 2024

SELL
$232.24 - $267.23 $63,866 - $73,488
-275 Reduced 21.57%
1,000 $243,000
Q2 2023

Jul 27, 2023

SELL
$238.39 - $265.32 $5,959 - $6,633
-25 Reduced 1.92%
1,275 $336,000
Q4 2022

Jan 24, 2023

BUY
$218.29 - $256.91 $283,777 - $333,983
1,300 New
1,300 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.